Immunotherapy in GU Cancers

March 23, 2015
Mark A. Rubin, MD

Special Reports, Immunotherapy (Issue 5), Volume 5, Issue 1

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

<<<

View the entire Special Report on Immunotherapy